Wang S S, Esplin E D, Li J L, Huang L, Gazdar A, Minna J, Evans G A
McDermott Center for Human Growth and Development, The University of Texas Southwestern Medical Center, Dallas, Texas 75235, USA.
Science. 1998 Oct 9;282(5387):284-7. doi: 10.1126/science.282.5387.284.
The PPP2R1B gene, which encodes the beta isoform of the A subunit of the serine/threonine protein phosphatase 2A (PP2A), was identified as a putative human tumor suppressor gene. Sequencing of the PPP2R1B gene, located on human chromosome 11q22-24, revealed somatic alterations in 15% (5 out of 33) of primary lung tumors, 6% (4 out of 70) of lung tumor-derived cell lines, and 15% (2 out of 13) of primary colon tumors. One deletion mutation generated a truncated PP2A-Abeta protein that was unable to bind to the catalytic subunit of the PP2A holoenzyme. The PP2R1B gene product may suppress tumor development through its role in cell cycle regulation and cellular growth control.
PPP2R1B基因编码丝氨酸/苏氨酸蛋白磷酸酶2A(PP2A)A亚基的β亚型,被鉴定为一种假定的人类肿瘤抑制基因。位于人类11号染色体q22 - 24区域的PPP2R1B基因测序显示,15%(33例中的5例)的原发性肺癌、6%(70例中的4例)的肺癌衍生细胞系以及15%(13例中的2例)的原发性结肠癌存在体细胞改变。一个缺失突变产生了一种截短的PP2A - Abeta蛋白,该蛋白无法与PP2A全酶的催化亚基结合。PP2R1B基因产物可能通过其在细胞周期调控和细胞生长控制中的作用来抑制肿瘤发展。